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Abstract
Background: Most diagnostic tests for acute uncomplicated urinary tract infections (UTIs) have been
previously studied in so-called single-test evaluations. In practice, however, clinicians use more than one
test in the diagnostic work-up. Since test results carry overlapping information, results from single-test
studies may be confounded. The primary objective of the Amsterdam Cystitis/Urinary Tract Infection
Study (ACUTIS) is to determine the (additional) diagnostic value of relevant tests from patient history and
laboratory investigations, taking into account their mutual dependencies. Consequently, after suitable
validation, an easy to use, multivariable diagnostic rule (clinical index) will be derived.
Methods: Women who contact their GP with painful and/or frequent micturition undergo a series of
possibly relevant tests, consisting of patient history questions and laboratory investigations. Using urine
culture as the reference standard, two multivariable models (diagnostic indices) will be generated: a model
which assumes that patients attend the GP surgery and a model based on telephone contact only. Models
will be made more robust using the bootstrap. Discrimination will be visualized in high resolution
histograms of the posterior UTI probabilities and summarized as 5th, 10th, 25th 50th, 75th, 90th, and 95th
centiles of these, Brier score and the area under the receiver operating characteristics curve (ROC) with
95% confidence intervals. Using the regression coefficients of the independent diagnostic indicators, a
diagnostic rule will be derived, consisting of an efficient set of tests and their diagnostic values.
The course of the presenting complaints is studied using 7-day patient diaries. To learn more about the
natural history of UTIs, patients will be offered the opportunity to postpone the use of antibiotics.
Discussion: We expect that our diagnostic rule will allow efficient diagnosis of UTIs, necessitating the
collection of diagnostic indicators with proven added value. GPs may use the rule (preferably after suitable
validation) to estimate UTI probabilities for women with different combinations of test results. Finally, in
a subcohort, an attempt is made to identify which indicators (including antibiotic treatment) are useful to
prognosticate recovery from painful and/or frequent micturition.
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Background
General background
An acute uncomplicated urinary tract infection (UTI, cys-
titis) is defined as an infection of the lower urinary tract
(bladder) in an otherwise healthy, nonpregnant, adult
woman without known anatomical or functional abnor-
malities of the urinary tract. [1-4] A U.S. study reported a
60% lifetime risk of physician-diagnosed UTI.[5]
The main symptoms suggesting a UTI are dysuria and uri-
nary frequency, whereas vaginal irritation and discharge
have been reported to reduce the probability of a UTI
being present.[6] Besides a UTI, an important cause of
dysuria and frequency is a Chlamydia  urethritis. Other
infectious diseases in the differential diagnosis of a UTI
are other types of urethritis (e.g. gonorrhoea), vaginitis,
interstitial cystitis and genital herpes. [6-8] Since a UTI dif-
fers from these diseases in its natural course and treat-
ment, a correct diagnosis is essential.
Empirical treatment of symptomatic women has been
reported to be cost-effective.[9,10] However, only half of
symptomatic women are found to have a UTI if defined by
≥ 105 colony-forming units (CFU)/ml.[11,12] Moreover,
bacterial resistance to commonly used antibiotics (e.g. tri-
methoprim and fluoroquinolones) is rising, suggesting
the need for more evidence-based prescribing. [13-16]
Better diagnosis of UTIs might prevent women from being
unnecessarily treated with antibiotics and be even more
cost-effective.
Diagnostic work-up
Diagnosis of UTIs in general practice consists of various
medical history questions and laboratory investigations,
of which nitrite and leukocyte esterase (LE) dipstick tests,
microscopic examination of urinary sediment, and
dipslide are the ones most widely used.
Most diagnostic tests for UTIs have been studied before in
single-test evaluations, implying that a test is compared to
the urine culture, not taking into account the distribution
of other test results in the population studied. [17-19] In
practice, however, the diagnostic work-up is inherently
multivariable, and test results are mutually dependent.
[20-36] Therefore it cannot be generally expected that a
test's sensitivity is invariant over different degrees of prior
testing. For example, the sensitivity of the nitrite dipstick
test will be affected by the information contained in the
diagnostic profile resulting from prior test results.[37]
The primary objective of the Amsterdam Cystitis/Urinary
Tract Infection Study (ACUTIS) is to determine the (addi-
tional) diagnostic value of relevant tests from patient his-
tory and laboratory investigations, taking into account
their mutual dependencies. Next, an easy to use, multivar-
iable diagnostic rule (clinical index) will be derived. After
suitable (external) validation, GPs may use the (vali-
dated) rule to estimate UTI probabilities for women with
different combinations of test results.
Little et al. and McIsaac et al. described similar work in a
UK and a Canadian population, respectively.[38,39]
However, different inclusion criteria were used (see fur-
ther) and urine samples were transported as in routine
practice before cultures were made, whereas in ACUTIS, to
assure reliability of the cultures (= reference standard),
urine samples are being refrigerated until being cultured.
Furthermore, both earlier studies did not assess diagnostic
values of the sediment and dipslide investigations.
Other similar studies.[40,41] were performed before the
European Urinalysis Guidelines.[42] recommended a cut-
off value of 103 cfu/ml for significant Escherichia coli bac-
teriuria and therefore only used the traditional cut-off
value of 105 cfu/ml. Besides, they did not assess dipstick
investigations and/or were not performed in a primary
care setting.[41]
Prognosis and natural history
Placebo arms of randomized controlled trials suggest that
25 to 50% of women presenting with a combination of
UTI-symptoms and bacteriuria will have recovered in one
week without using antibiotics. [43-45] Using data from
ACUTIS, we will try to make a prognostic index. Using the
prognostic index, a GP can estimate the 7-day course for
women with different combinations of test results and




ACUTIS is performed in general practices and primary
health care centers in Amsterdam and surroundings,
which altogether comprise 20 practices of average size
(total source population = 46,000 patients).
Design
In a prospective cohort, each participating patient will be
followed for 7 days. At baseline, potentially relevant signs
and symptoms will be recorded and potentially relevant
laboratory tests (dipstick, sediment and dipslide) will be
performed, along with a urine culture as reference test.
Details are described below.
Study population
Eligible are female patients over 12 years of age, contact-
ing their GP with painful and/or frequent micturition. The
symptoms may have been present for a maximum of 7
days. Although not being adult and therefore not strictly
meeting the definition of acute uncomplicated urinaryBMC Family Practice 2008, 9:64 http://www.biomedcentral.com/1471-2296/9/64
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tract infection, patients between the age of 12 and 18 are
eligible, as their urogenital tract is expected to be anatom-
ically similar to that of adult women.
Exclusion criteria are: pregnancy, lactation, signs of
pyelonephritis, being immunocompromised (e.g. receiv-
ing radiotherapy or immunosuppressants, being HIV
infected) with the exception of diabetes mellitus, having
used antibiotics for another indication than UTI or having
undergone a urological procedure in the past two weeks,
and known anatomical or functional abnormalities of the
urogenital tract.
To ensure a clinical domain in which the diagnostic index
may be expected to perform as reported and to enhance
generalizability in time and place, we use clearly formu-
lated eligibility criteria. This differs from similar studies,
in which patients were eligible when GPs "suspected" a
UTI, based on their personal judgement.[38,39]
Informed consent
A letter with information about the study is provided to
all patients. Participating women must provide written
informed consent prior to enrollment. For patients under
the age of 18 written parental authorization is required.
Sample size
When the events per variable (EPV) rule.[46,47] is applied
on a number of 15 possible diagnostic indicators and
taken into account that some indicators will have to be
modeled as dummy variables, about 200 women with a
UTI are needed for this study (although a more recent sim-
ulation study suggests that the traditional EPV figure may
be an overestimate.[48], so that less patients may be
needed for our study). Assuming that the probability of a
UTI (if defined by ≥ 105 CFU/ml) in eligible women is
approximately 50%.[11,12] (range 40–60%), between
333 and 500 women will have to be included in the study.
According to a UTI incidence in The Netherlands of 68 per
1000 women per year.[49], 157 women per year are diag-
nosed with a UTI in a general practice of average size.
Assuming that 80% of all eligible women will not take
part in the study, 16–17 practices of average size that
include patients for a period of 1 year are needed (500/
(157 × (1-0.8)) = 16.03).
Clinical assessments (see table 1)
After eligibility has been confirmed and informed consent
has been obtained, urine is collected in a sterile container.
Instructions for the collection method may be given at the
GP's discretion, but are not necessary, as they have been
reported to have no consequences for the extent of con-
tamination. [50-52] We insist that the urine sample is col-
lected at the GP surgery, since collection at home will
cause at least some specimens to remain non-refrigerated
for too long, thus rendering urinalysis unreliable.[53]
After urine collection, patients are asked to fill in a
detailed questionnaire to record presence and severity of
signs and symptoms (see additional file 1). Furthermore,
they are given a special diary, in which they are to record
clinical symptoms and any use of antibiotics for 7 days.
The GP or GP assistant performs a dipstick test (Multistix®
5, Siemens Medical Solutions Diagnostics™) and a
dipslide test (Uricult® classic, Orion diagnostica™). Dip-
sticks will be assessed automatically by a Clinitek Status®
analyzer (Siemens Medical Solutions Diagnostics™) to
reduce inter-observer variation.
Immediately after dipstick and dipslide investigations
have been performed, urine samples are stored in a refrig-
erator at the GP surgery. Within 8 hours they are trans-
ported to two laboratories (see below) at 4°C by a
specialized courier service.
GPs are free to perform a urinary sediment investigation,
the results of which will then be documented. However,
in the statistical analysis we will assess the diagnostic
value of the urinary sediment investigation performed by
Table 1: Assessment schedule
GP or GP assistant Patient
day 1 (baseline) Check availability
Obtain informed consent
Collect urine at GP surgery
Perform dipstick and dipslide (and optionally sediment) Fill in questionnaire
Send urine to laboratory (refrigerated) for culture and sediment
day 2 Examine dipslide
day 1 till day 7 Record symptoms in diary
day 8 If patient did not use antibiotic: collect urine and send for cultureBMC Family Practice 2008, 9:64 http://www.biomedcentral.com/1471-2296/9/64
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experts at the Laboratory for Clinical Chemistry of the
Academic Medical Center in Amsterdam. Only if the sedi-
ment investigation proves to be useful under the optimal
conditions of the laboratory, we will repeat it under daily
practice conditions in a sub-study to be carried out after
the main study has been completed (see further).
The Laboratory for Medical Microbiology of the Academic
Medical Center in Amsterdam performs a urine culture,
which serves as the reference standard. Trained laboratory
technicians, who have no information on previous test
results from history taking and/or urinalysis, will make a
culture according to the standard loop method.[53], inter-
pret the culture results and determine resistance patterns.
Patients who have not used antibiotics since their study
entry will be asked to provide another urine sample for
culturing at day 7 (see below).
Urine samples with a culture result ≥ 102 CFU/ml will be
stored refrigerated for possible later use (e.g. identifica-
tion of bacterial strains).
Data entry
The information obtained from patient history and labo-
ratory investigations will be collected and entered into a
structured database by a qualified commercial data-entry
service, which guarantees a 97% accuracy at character
level. For crucial variables (e.g. culture results) there will




The data will be screened for data entry errors, extreme
values, and missing values using simple tables, plots, and
dedicated commands to identify (multivariable) outliers.
Errors will be corrected. Instead of deleting extreme cases,
we shall consider to suitably truncate extreme values
where their influence on models appears too strong.[54]
Missing values
Multiple imputation using chained equations will be used
to impute missing values.[55,56]
Dependent variable
The results of the urine culture will be used as the depend-
ent variable. A cut-off value of 103 CFU/ml will be used to
define a positive culture, as is recommended by the Euro-
pean Urinalysis Guidelines.[42] We will explore how sen-
sitive the model is to the use of different cut-off values for
defining a positive culture.[6,12,57-60]
Theoretically, false positive reference standard results may
occur if women with asymptomatic bacteriuria are
included in the study when they visit their GP with com-
plaints similar to UTI symptoms but caused by a different
disease (e.g. vaginitis). In the community, the prevalence
of asymptomatic bacteriuria has been reported to be 1 to
5% in premenopausal, nonpregnant women, growing




We aim to generate two models (diagnostic indices). First,
a model which assumes that patients attend the GP sur-
gery. Second, a model based on telephone contact only,
since in daily routine this is very often the first and only
contact with the patient.
Finally, using different threshold probabilities for 'no fur-
ther action' (e.g. advice to increase the intake of water,
'wait and see') and prescription of an antibiotic, respec-
tively, we will develop a diagnostic test algorithm such
that patients may undergo the least number of possible
tests. That is, if, regardless of its results, a certain test can
be shown not to take a patient across one of the above-
mentioned thresholds for specific clinical action, that test
may be informative, but not sufficiently so to change
management. Therefore it is superfluous. It is possible
that a 'telephone only' model provides sufficient certainty
for patients with specific combinations of patient history
items, while for other patients urinalysis at the GP surgery
is needed to decide on management correctly.
Variable selection
At the time of writing, a failsafe model selection strategy
on which all statisticians and other experts in diagnostic
and predictive modeling agree does not appear to exist.
However, in his book 'Regression modeling strategies
(2001)'[62], Harrell made some general proposals for
researchers to tailor to the specific circumstances. We
intend to use penalized logistic regression, and Tib-
shirani's  lasso  (least absolute shrinkage and selection
operator)[63] in particular to combine the requirements
of counteracting over-optimism (shrinkage of regression
coefficients) while leaving the opportunity that some
coefficients are set to zero, which serves the requirement
of a parsimonious model. Bootstrapping will be used to
estimate the penalization coefficient.[62] As a form of
sensitivity analysis, we shall also explore bootstrapped
stepwise regression[64,65] to see how well these
approaches concur. We will avoid univariable preselec-
tion of predictors. The linearity assumption will be
checked for all continuous predictors.
Discrimination of the model(s) will be visualized in high
resolution histograms and summarized as 5th, 10th, 25th
50th, 75th, 90th, and 95th centiles of these, Brier score andBMC Family Practice 2008, 9:64 http://www.biomedcentral.com/1471-2296/9/64
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the area under the receiver operating characteristics curve
(ROC) with 95% confidence intervals (overall discrimina-
tion).[66]
Using the regression coefficients of the independent diag-
nostic indicators, an easy to use, multivariable diagnostic
rule (clinical index) will be derived, consisting of relevant
tests and their diagnostic values.
Substudies
Prognosis
Using our diagnostic rule, the probability of a positive cul-
ture at baseline can be estimated. For a clinician it may
also be relevant to learn more about a patient's prognosis
and how this is affected by antibiotic medication. In pre-
vious studies 25 to 50% of women presenting with UTI
symptoms and/or bacteriuria have been reported to
recover spontaneously within one week. [43-45] It would
be useful to know whether these patients, for whom anti-
biotics are not indicated, can be identified at baseline
based on their clinical profiles.
In ACUTIS, all patients are asked to record their symptoms
and possible antibiotic use in a special diary for 7 days. To
learn more about the natural course of UTI, we will offer
eligible women the opportunity to postpone the use of
antibiotics. For patients who have not used antibiotics
after 7 days, we shall try to secure a second urine specimen
for culture. As a result, two prognostic models may be
developed, with clinical and bacteriological cure after one
week serving as dependent variables, respectively. Regres-
sion analysis will be used to assess the effects of antibiotic
treatment using all cogent potential confounders to coun-
teract possible confounding by indication as much as pos-
sible. If in specific subdomains of women no effect of
antibiotics is found, randomised trials may be indicated
to confirm such findings. If, on the other hand, an effect
is found, the effect may be non-existent in particular sub-
groups. However, the power to detect such subgroup
effects (or a lack of it) is probably somewhat limited.
Women with milder symptoms may be more likely to
defer antibiotics. We consider this not to be a great prob-
lem, since this is the subdomain of patients in which
doubt about the value of antibiotics is greatest. Placebo-
controlled randomized clinical trials in the subdomain of
patients with severe dysuria and/or frequency are likely to
incur ethical problems. If our results are promising, how-
ever, an RCT may be performed in the future (possibly by
using a delayed prescription approach. [67-69]).
Sediment
As mentioned before, urinary sediment investigation will
be performed under protocollized circumstances at the
Laboratory for Clinical Chemistry. It could be argued that
this should be done in the GP surgery, as this is more in
accordance with common practice. However, if urinary
sediment proves to be useful under the optimal condi-
tions of the laboratory, it will be repeated under daily
practice conditions in a sub-study after the main study has
been completed. The originally obtained sediment data
can then be replaced in our model by the daily practice
results, using Deming (orthogonal) regression analysis.
[70-76] Briefly, this is a method that can be used to esti-
mate the relationship between two measurements with
proportional errors, in this case sediment under optimal
conditions and sediment under daily practice conditions.
The data collection of this sediment sub-study will take
place during a specially organized training session, where
sediment scoring results of GPs and/or GP assistants will
be measured before and after training by experts. Sedi-
ment investigation on the same samples will be per-
formed by experts under optimal conditions (= reference
standard). The before-training measurements as well as
the after-training measurements will be compared with
the expert measurements using Deming regression.
Chlamydia/gonorrhoea
Apart from a UTI, dysuria and urinary frequency in sexu-
ally active women may be a result of a urethritis caused by
Chlamydia trachomatis or Neisseria gonorrhoeae. Therefore a
polymerase chain reaction (PCR) for Chlamydia trachoma-
tis and Neisseria gonorrhoeae will be done in each urine
sample. An attempt will be made to extend our diagnostic
rule for Chlamydia trachomatis and Neisseria gonorrhoeae
infections in women with painful and/or frequent mictu-
rition. To attain this, we will perform a polytomous logis-
tic regression analysis, a technique that is used to
simultaneously estimate probabilities of multiple diag-
noses. [77-79] As a result, a diagnostic model with three
outcomes (UTI, Chlamydia trachomatis, and Neisseria gon-
orrhoeae) can be derived.
Discussion
Whereas most previous studies on diagnosis of UTIs are
single-test evaluations, we will perform a multivariable
analysis and develop an easy to use diagnostic rule for
general practice. This will allow efficient diagnosis of
UTIs, using only those diagnostic indicators which have
proven added value to rule in or rule out UTI. For a large
number of women with painful and/or frequent micturi-
tion, additional urine investigations might prove to add
no useful information to what is already known from spe-
cific patient history questions.
This implies that in these cases the diagnostic procedure
can be completed by telephone, which makes life easier
for GP and patient alike. Another possibility is that
patients, before contacting their GP, use a simplified ques-
tionnaire (based on the study results), available e.g. from
the Internet or from their GP's office. As a result, the diag-BMC Family Practice 2008, 9:64 http://www.biomedcentral.com/1471-2296/9/64
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nostic work-up will be more cost-effective and less time-
consuming. Besides, since use of dipslide and culture
might be reduced, there may be less time delay in UTI
diagnosis.
In sub-studies we will try to extend our diagnostic rule to
diagnosis of Chlamydia trachomatis or  Neisseria gonor-
rhoeae. Furthermore, prognostic indicators (potentially
including antibiotics) of the 7-day course of painful and/
or frequent micturition will be assessed in our cohort
study.
We expect to be able to submit the first results of ACUTIS
no later than by the end of 2009.
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